Next 10 |
home / stock / mdp:cc / mdp:cc news
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) and medac, licensor of Medexus's c...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...
Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 million Management to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 7, 2024) - Medexus Pharm...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 8, 2024 to discuss Medexus's results for its third fiscal quarter ended December 31, 20...
Topical terbinafine has been widely used in other markets to treat fungal nail infections If and when approved, the product will enter the topical fungicides market that is estimated to be C$88 million on an annual basis* Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 8, 2...
Whitemud Resources Inc. (WMK:CA) is expected to report for quarter end 2023-09-30 Avanti Helium Corp. (AVN:CA) is expected to report for quarter end 2023-09-30 Advantex Marketing International Inc (ADX:CNX) is expected to report for quarter end 2023-09-30 Royal Helium Ltd. (RHC:CA) is...
Nubian Resources Ltd. (NBR:CA) is expected to report for quarter end 2023-10-31 EQB Inc. (EQB:CA) is expected to report $2.97 for Q3 2023 Magna Gold Corp. (MGR.H:CA) is expected to report for quarter end 2023-09-30 Royal Helium Ltd. (RHC:CA) is expected to report for quarter end 2023-...
Allkem Limited Ordinary Shares (AKE:CA) is expected to report $0.05 for Q1 2024 Wall Financial Corporation (WFC:CA) is expected to report for Q2 2024 Avanti Helium Corp. (AVN:CA) is expected to report for quarter end 2023-09-30 Transcontinental Inc. Class B Multiple Voting Shares (TCL...
Mistango River Resources Inc (MIS:CNX) is expected to report for quarter end 2023-09-30 Forza Petroleum Limited (FORZ:CA) is expected to report for Q1 2024 Whitemud Resources Inc. (WMK:CA) is expected to report for quarter end 2023-09-30 Elemental Altus Royalties Corp. (ELE:CA) is exp...
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc. Company Name:
MDP:CC Stock Symbol:
TSXC Market:
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) and medac, licensor of Medexus's c...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...